Chemistry: molecular biology and microbiology – Differentiated tissue or organ other than blood – per se – or...
Reexamination Certificate
2011-08-30
2011-08-30
Saucier, Sandra (Department: 1657)
Chemistry: molecular biology and microbiology
Differentiated tissue or organ other than blood, per se, or...
C435S001200
Reexamination Certificate
active
08007993
ABSTRACT:
A storage solution to maintain and perfuse organs awaiting transplantation comprising (a) an isotonic balanced solution comprising a physiologically acceptable amount of potassium, mono acidic phosphate, biacidic phosphate, chloride, sodium and bicarbonate ions; (b) 50-250 mM glucose; (c) 0.2-20 mM of an alkanoyl L-carnitine or a physiologically acceptable salt thereof; (d) 1-100 mM of L-carnitine or a physiologically acceptable salt thereof; (e) water is described. The storage solution can also include other components such as anti-oxidants and/or chelating agents.
REFERENCES:
patent: 5498427 (1996-03-01), Menasche
patent: 5834178 (1998-11-01), Churchill et al.
patent: RE36331 (1999-10-01), Arduini
patent: 6822002 (2004-11-01), Arduini
patent: 7422844 (2008-09-01), Arduini et al.
patent: 96/18293 (1996-06-01), None
patent: 96/40167 (1996-12-01), None
patent: 00/30637 (2000-06-01), None
Caldwell-Kenkel et al., “Reperfusion injury to endothelial cells after cold storage of rat livers: protection by mildly acidic pH and lack of protection by antioxidants”, Transplantation International 8 : 77-85 (1995).
Racey-Burns et al., “The effect of dichloroacetate on the isolated no flow arrested rat heart”, Life Sciences 44 (26) : 2015-2023 (1989).
Database Biosis ′Online; Biosciences Information Service, Philadelphia, PA, US: 1990, Klepetko et al; Pulmonary Surfactant in Bronchoalveolar Lavage After Canine Lung Transplantation Effect of L Carnitine Application; Database Accession No. PREV199090067674; XP002215925.
Database Medline ′Online; Apr. 1994; Nakagawa et al; “The Effect of L-Carnitine on Myocardial Protection in Coid Cardioplegia Followed by Reperfusion”; Database Accession No. NLM8016834; XP002215926.
O. Ergun et al; “Carnitine As Preventive Agent in Experimental Renal Ischemia-Perfusion Injury”; Urological Research, vol. 29, No. 3, Jun. 11, 2001, pp. 186-189, XP002215923.
U. Puetz et al; “Effects of L-Carnitine-Hydrochloride in the Cold Ischemic Preservation of Fatty Liver Grafts”; Transplantation Proceedings, vol. 33, 2001, pp. 2523-2524, XP002215924.
Database Biosis Online; Biosciences Information Service, Philadelphia, PA, US; Mar. 2002, Mister Marilena et al; “Propionyl-L-Carnitine Prevents Renal Function Deterioration Due to Ischemia/Reperfusion”; Database Accession No. PREV200200206973, XP002215927.
Database Medline ′Online, 1992, Reckendorfer et al; “Hepatic Energy Metabolism During Hypothermic Storage and Reperfusion Using Different Protecting Solutions”; Database Accession No. NLM1292938, XP002215928.
Kasperk et al, “Morphometric Study of Centrilobular Vessels in the Rat Liver After Continuous Perfusion With Euro-Collins and University of Wisconsin Solution”, Research in Experimental Medicine 194 (6): 383-90 (1994).
Rossaro et al, “Phosphorus 31-Nuclear Magnetic Resonance Spectroscopy of Rat Living During Simple Storage of Continuous Hypothermic Perfusion”, Journal of Laboratory and Clinical Medicine 120 (4): 559-68 (1992).
Boehmova et al, “Renal Ischemia-Reperfusion Injury: An Inescapable Event Affecting Kidney Transplantation Outcome”, Folia Microbiologica 46 (4): 267-276 (2001).
Loster et al, “Effects of L-Carnitine and Its Acetyl and Propionyl Esters on ATP and PCR Levels of Isolated Rat Hearts Perfused Without Fatty Acids and Investigated by Means of 31P-NMR Spectroscopy”, Molecular and Cellular Biochemistry 200: 93-102 (1999).
Niu et al., “Enhancement of Hypothermic Heart Preservation with Fructose 1, 6-Diphosphate” J. Clinical Res. 85: 120-129, 1999.
Skerde at al., “Coenzyme A in dog kidneys during hypothermic perfusion” Chemical Abstracts Service, Cryobiology, vol. 20, No. 3, 1983, pp. 290-297.
Arduino Arduini
Tommaso Aureli
Lucas & Mercanti LLP
Saucier Sandra
Sigma—Tau Industrie Farmaceutiche Riunite, S.p.A.
LandOfFree
Method for storage and perfusion of organs using a solution... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for storage and perfusion of organs using a solution..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for storage and perfusion of organs using a solution... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2748269